Cargando…

The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants

Although there are currently 62 mutants of Cx43 (connexin43) that can cause ODDD (oculodentodigital dysplasia), only two mutants have also been reported to cause palmar plantar hyperkeratosis. To determine how mutants of Cx43 can lead to this skin disease, REKs (rat epidermal keratinocytes) were eng...

Descripción completa

Detalles Bibliográficos
Autores principales: Churko, Jared M., Langlois, Stephanie, Pan, Xinyue, Shao, Qing, Laird, Dale W.
Formato: Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907710/
https://www.ncbi.nlm.nih.gov/pubmed/20515445
http://dx.doi.org/10.1042/BJ20100155
_version_ 1782184133595758592
author Churko, Jared M.
Langlois, Stephanie
Pan, Xinyue
Shao, Qing
Laird, Dale W.
author_facet Churko, Jared M.
Langlois, Stephanie
Pan, Xinyue
Shao, Qing
Laird, Dale W.
author_sort Churko, Jared M.
collection PubMed
description Although there are currently 62 mutants of Cx43 (connexin43) that can cause ODDD (oculodentodigital dysplasia), only two mutants have also been reported to cause palmar plantar hyperkeratosis. To determine how mutants of Cx43 can lead to this skin disease, REKs (rat epidermal keratinocytes) were engineered to express an ODDD-associated Cx43 mutant always linked to skin disease (fs260), an ODDD-linked Cx43 mutant which has been reported to sometimes cause skin disease (fs230), Cx43 mutants which cause ODDD only (G21R, G138R), a mouse Cx43 mutant linked to ODDD (G60S), a non-disease-linked truncated Cx43 mutant that is trapped in the endoplasmic reticulum (Δ244*) or full-length Cx43. When grown in organotypic cultures, of all the mutants investigated, only the fs260-expressing REKs consistently developed a thinner stratum corneum and expressed lower levels of Cx43, Cx26 and loricrin in comparison with REKs overexpressing wild-type Cx43. REKs expressing the fs260 mutant also developed a larger organotypic vital layer after acetone-induced injury and exhibited characteristics of parakeratosis. Collectively, our results suggest that the increased skin disease burden exhibited in ODDD patients harbouring the fs260 mutant is probably due to multiple additive effects cause by the mutant during epidermal differentiation.
format Text
id pubmed-2907710
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-29077102010-07-22 The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants Churko, Jared M. Langlois, Stephanie Pan, Xinyue Shao, Qing Laird, Dale W. Biochem J Research Article Although there are currently 62 mutants of Cx43 (connexin43) that can cause ODDD (oculodentodigital dysplasia), only two mutants have also been reported to cause palmar plantar hyperkeratosis. To determine how mutants of Cx43 can lead to this skin disease, REKs (rat epidermal keratinocytes) were engineered to express an ODDD-associated Cx43 mutant always linked to skin disease (fs260), an ODDD-linked Cx43 mutant which has been reported to sometimes cause skin disease (fs230), Cx43 mutants which cause ODDD only (G21R, G138R), a mouse Cx43 mutant linked to ODDD (G60S), a non-disease-linked truncated Cx43 mutant that is trapped in the endoplasmic reticulum (Δ244*) or full-length Cx43. When grown in organotypic cultures, of all the mutants investigated, only the fs260-expressing REKs consistently developed a thinner stratum corneum and expressed lower levels of Cx43, Cx26 and loricrin in comparison with REKs overexpressing wild-type Cx43. REKs expressing the fs260 mutant also developed a larger organotypic vital layer after acetone-induced injury and exhibited characteristics of parakeratosis. Collectively, our results suggest that the increased skin disease burden exhibited in ODDD patients harbouring the fs260 mutant is probably due to multiple additive effects cause by the mutant during epidermal differentiation. Portland Press Ltd. 2010-07-14 2010-08-01 /pmc/articles/PMC2907710/ /pubmed/20515445 http://dx.doi.org/10.1042/BJ20100155 Text en © 2010 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by-nc/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Churko, Jared M.
Langlois, Stephanie
Pan, Xinyue
Shao, Qing
Laird, Dale W.
The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
title The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
title_full The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
title_fullStr The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
title_full_unstemmed The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
title_short The potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
title_sort potency of the fs260 connexin43 mutant to impair keratinocyte differentiation is distinct from other disease-linked connexin43 mutants
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907710/
https://www.ncbi.nlm.nih.gov/pubmed/20515445
http://dx.doi.org/10.1042/BJ20100155
work_keys_str_mv AT churkojaredm thepotencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT langloisstephanie thepotencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT panxinyue thepotencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT shaoqing thepotencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT lairddalew thepotencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT churkojaredm potencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT langloisstephanie potencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT panxinyue potencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT shaoqing potencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants
AT lairddalew potencyofthefs260connexin43mutanttoimpairkeratinocytedifferentiationisdistinctfromotherdiseaselinkedconnexin43mutants